Product Information
IVERMECTIN 3 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $2.1737 per EA under NDC 72888020666. Its NADAC has been published 55 times since Jun 11, 2025.
Strength
3 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888020666
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IVERMECTINApproval Type
Generic (ANDA)
FDA Application
ANDA215922On Market Since
1/22/2025
Pharmacological Classes
Price Statistics
The NADAC for IVERMECTIN 3 MG TABLET has been published 55 times since Jun 11, 2025, and over the history we have for it it has declined 32.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1737 per EA |
|---|---|
| All-time high | $3.2331 (Jun 11, 2025) |
| All-time low | $2.1737 (Jun 17, 2026) |
| 52-week high | $3.1722 |
| 52-week low | $2.1737 |
| Median price | $3.0504 |
| Average price | $2.8249 |
| Largest weekly change | -7.8% (Feb 18, 2026) |
| Weeks tracked | 55 |
| Tracking since | Jun 11, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IVERMECTIN 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IVERMECTIN 3 MG TABLET, manufactured by Advagen Pharma Ltd., is $2.1737 per EA (NDC 72888020666), effective Jun 24, 2026.
How has the price of IVERMECTIN 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for IVERMECTIN 3 MG TABLET has declined 32.8%. It has been tracked across 55 weekly CMS publications since Jun 11, 2025.
What are the highest and lowest recorded NADAC prices for IVERMECTIN 3 MG TABLET?
Since Jun 11, 2025, the NADAC for IVERMECTIN 3 MG TABLET has ranged from a low of $2.1737 (Jun 17, 2026) to a high of $3.2331 (Jun 11, 2025), with a median of $3.0504 per EA.
Are there cheaper alternatives to IVERMECTIN 3 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as IVERMECTIN 3 MG TABLET, but none are currently priced below it.
Who manufactures IVERMECTIN 3 MG TABLET?
IVERMECTIN 3 MG TABLET (NDC 72888020666) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification